I didn't have any expectations at all really. Purely just assessing the research data and providing insight for those who may or may not understand what this paper means in the grand scheme of things.
Personally the market cap is irrelevant to me (unless comparing two potential investments with similar risk profiles and future productivity/earnings). More important for OCC, atm, is research stage, efficacy, safety, side effect profiles, human studies and whether there are any other products in development from other research groups/companies which may usurp this POTENTIAL health product.
My sentiment is sell, I think Orange is on the money - the severity of the price movement is not justified by the announcement.
I didn't have any expectations at all really. Purely just...
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
0.010(2.60%) |
Mkt cap ! $82.68M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 39.5¢ | 38.5¢ | $28.61K | 74.11K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 5000 | 1 |
View Market Depth
| Last trade - 15.57pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
39.5¢ |
Change
0.010 ( 2.60 %) |
||||
| Open | High | Low | Volume | ||
| 39.5¢ | 39.5¢ | 39.5¢ | 2000 | ||
| Last updated 14.09pm 03/05/2024 ? | |||||
| OCC (ASX) Chart |